350 rub
Journal №8 for 2010 г.
Article in number:
Hemorheologic effects of polyphenols from far east plant maackia amurensis in ovariectomized rats
Authors:
А.М. Plotnikova, Z.T. Shulgau, T.M. Plotnikova, O.I. Aliev, N.I. Kulesh, N.P. Mischenko, S.A. Fedoreyev
Abstract:
The effect of Maackia amurensis extract (EMA) on plasma estradiol and rheological properties of blood in female Wistar rats after ovariectomy was investigated. We measured the hematocrit, fibrinogen concentration, erythrocytes aggregation, erythrocytes deformability and whole blood viscosity after bilateral ovariectomy in rats. The content of polyphenols in EMA according to HPLC was 21.6% (isoflavonoids - 12.7% and stilbenes - 8.9%). The high maintenance of isoflavonoid-phytoestrogen in EMA was the basis for studying its effects in hypoestrogenic conditions. Ovariectomy in rats induced the decrease of estrogen level to 60% in comparison with a level in sham-operated animals. The whole blood viscosity in ovariectomized rats was increased by 7-18% as a result of evaluation of hematocrit by 7%, as well as impairment of erythrocyte deformability and increase of their aggregation. Efficacy of O2-transport to tissues was decreased by 7%. Two weeks after surgery, the course treatment with extract of Maackia amurensis (oral administration 200 mg/kg/day during 14 days) in ovariectomized rats reduced the blood viscosity by 4-13% and increased the coefficient of O2-transport to tissues by 3-9%, but did not restore the estrogen level. The reason of EMA hemorheological effects was improvement of microrheological parameters: erythrocyte aggregation decrease and their deformability increase without the modification of macrorheological parameters (hematocrit and plasma viscosity). The present findings suggest that EMA could be used as a therapeutic agent for menopausal vascular complication.
Pages: 45-49
References
  1. Белкин А. В., Сторожок С. А., Катюхин Л. Н. Эктацитометрия ? объективный метод оценки способности эритроцитов к деформации // Физиол. журн. СССР им. И.М. Сеченова. 1991. Т. 77. № 1. С. 133 - 138.
  2. Белобородова Э.И., Венгеровский А.И., Гайсаев Р.О. Новое гепатозащитное средство - максар // Сибирский журнал гастроэнтерологии и гепатологии. 1999. №8. С. 443 - 445.
  3. Киршенблат Я. Д. Практикум по эндокринологии. М.: 1969.
  4. Левтов В. А., Регирер С. А.,. Шадрина И. Х. Реология крови. М.: 1982.
  5. Патент № 2104027 (РФ).
  6. Плотников М. Б., Колтунов А. А., Алиев О. И. Модификация микроколориметра МКМФ-1 для регистрации агрегации эритроцитов // Клин. лаб. диагностика. 1995. №3. С. 457 - 458.
  7. Сметник В. П., Тумилович Л. Г. Неоперативная гинекология: Руководство для врачей. М. 2002.
  8. Федореев С. А., Кулеш Н. И., Глебко Л. И. Препарат максар из дальневосточного растения маакии амурской // Химико-фармацевтический журнал. 2004. Т. 38. №11. С. 56 - 59.
  9. Vaya A., Chorro P., Julia D., et al. Menopause, hormone replacement therapy and hemorheology // Clinical Hemorheology and Microcirculation. 2004. V. 30. Nо. 3 - 4. P. 277 - 281.
  10. Rossouw J.I., Anderson G.L., Prentice R.L. Risk and benefits of estrogen plus progestin in healthy postmenopausal women principal results from the women´s health initiative randomized controlled trial // J Am Med Assjc. 2002. V. 288. P. 321 - 333.
  11. Mathienson R.A., Kitts W.D. Binding of phytoestrogens and oestradiol-17b by cytoplasmic receptors in the pituitary gland and hypothalamus of the ewe // Endocrinology. 1980. V. 85. P. 317 - 325.